Revelation Biosciences, Inc. (REVBW) stock
REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $16.05MP/E –Yield –
Revelation Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Revelation Biosciences's price to book ratio was 1.3× on Oct 19, 2026, against 2.0× a year earlier. Over the last 2 years it ranged from 0.2× to 447.1×, with a median of 2.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 1.3× | +0.2 |
| 2025 | Dec 31, 2025 | 1.0× | −381.2 |
| 2024 | Jul 31, 2024 | 382.3× | – |